Latest Capital Management News

Jayride Group continues its pivot to a SaaS mobility platform across Australasia and Southeast Asia, managing tight cash flow and planning a capital raise to sustain operations and support ASX reinstatement.

LTR Pharma highlights SPONTAN's 5x faster absorption and validated safety, backed by over 1,000 Australian prescriptions and strategic partnerships as it targets FDA approval and US market entry.

DUG Technology Ltd recorded a 35% revenue increase in FY26-Q3, surpassing full-year FY25 revenue in just nine months and announcing a strategic move to half-year financial reporting.

Scentre Group has successfully tendered nearly 90% of its US$1.312 billion Non-Call 2030 Subordinated Notes, enabling full redemption and bolstering liquidity to A$3.2 billion. The group maintains its 2026 growth targets amid geopolitical uncertainty.

Scentre Group has successfully tendered 89% of its US$1.312 billion 2030 subordinated notes and plans to redeem the remainder, boosting liquidity to A$3.2 billion while maintaining 4% growth targets for 2026.

Resmed delivered a robust Q3 FY2026 with 11% revenue growth, margin expansion, and a 21% jump in non-GAAP EPS, while announcing a new U.S. distribution centre and a $0.60 dividend.

ANZ Group Holdings Limited posted a 14% rise in cash profit for 1H26 to AUD 3.78 billion, driven by cost reductions and steady revenue, while declaring an 83-cent interim dividend with 75% franking.

Aldoro Resources has defined high-priority gold targets at its Damara Gold Project and confirmed significant rare earth and associated mineralisation at Kameelburg, with drilling and metallurgical progress underpinning its dual-commodity strategy.

Strategic Energy Resources (ASX:SER) has locked in a $6 million joint venture with Sumitomo for its Bulimba Gold Project, secured $400,000 in government grants for drilling, and completed capital consolidation, positioning itself for a busy exploration season in Queensland.

Prairie Lithium has moved Pad #1 from groundwork to active building construction, backed by SaskPower's powerline installation and a binding Hydro Lithium offtake agreement that includes a A$10 million equipment contribution. First production is targeted for Q4 2026.

Epsilon Healthcare has achieved its highest quarterly receipts ever with $3.14 million in Q1 2026, driven by strong expansion across contract manufacturing, clinics, and pharmacy operations.

Beonic Limited’s Q3 FY26 results highlight a tripling of EBITDA margin to 15.8%, driven by operational leverage and gross margin expansion, while the Moroccan Airports rollout stays on track for full delivery by June 2026.